11
Mar

San Diego-based Acadia Pharmaceuticals put out word on Wednesday evening that it is delaying its expected NDA for pimavanserin from Q1 back to some time in the second half of this year. And the company says its CEO is out the door.

…read more

Source: Acadia craters as takeover buzz is silenced by (another) NDA delay, CEO exit

    

0 No comments